Clinical Trials · NCT00730015

Trial of Linaclotide in Patients With Chronic Constipation

CompletedPhase 3Linaclotide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ironwood Pharmaceuticals, Inc.
Enrollment
643
Start date
Aug 2008
Locations
105 sites, United States
Primary endpoint
Complete Spontaneous Bowel Movement (CSBM) Overall Responder
View Linaclotide compound reference